Radhakrishnan Senthil K, Feliciano Claudine S, Najmabadi Feridoon, Haegebarth Andrea, Kandel Eugene S, Tyner Angela L, Gartel Andrei L
Department of Medicine, University of Illinois at Chicago, 60612, USA.
Oncogene. 2004 May 20;23(23):4173-6. doi: 10.1038/sj.onc.1207571.
p21 is a potent inhibitor of cyclin-dependent kinases capable of arresting cell cycle progression. p21 is primarily regulated at the transcriptional level by several transcription factors, including p53. Previously, we reported that certain members of the E2F family of transcription factors may activate p21 transcription via a p53-independent mechanism. To further elucidate the consequences of E2F-1-regulated induction of p21, we developed cell lines with a tamoxifen-dependent form of E2F-1. We confirmed direct interaction of E2F-1 with the proximal region of the p21 promoter. Interestingly, elevated E2F-1 activity was sufficient to arrest a substantial subset of cells in S phase and this effect was correlated to and dependent on the induction of p21 protein. Since E2F proteins control genes required for cell cycle progression and are activated by various oncogenic events, we believe that the p21-dependent arrest described in this report represents an additional mechanism that guards against unrestricted cell proliferation.
p21是一种能有效抑制细胞周期蛋白依赖性激酶从而使细胞周期进程停滞的物质。p21主要在转录水平受包括p53在内的多种转录因子调控。此前,我们报道过转录因子E2F家族的某些成员可能通过一种不依赖p53的机制激活p21转录。为了进一步阐明E2F-1调控诱导p21的后果,我们构建了具有他莫昔芬依赖性形式的E2F-1的细胞系。我们证实了E2F-1与p21启动子近端区域的直接相互作用。有趣的是,升高的E2F-1活性足以使相当一部分细胞停滞在S期,并且这种效应与p21蛋白的诱导相关且依赖于p21蛋白的诱导。由于E2F蛋白控制细胞周期进程所需的基因并被各种致癌事件激活,我们认为本报告中描述的p21依赖性停滞代表了一种防止细胞无限制增殖的额外机制。